3-(1,3-Dioxoisoindolin-2-yl)-3-(naphthalen-2-yl)propanoic acid

ID: ALA4167674

Chembl Id: CHEMBL4167674

PubChem CID: 9862989

Max Phase: Preclinical

Molecular Formula: C21H15NO4

Molecular Weight: 345.35

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(O)CC(c1ccc2ccccc2c1)N1C(=O)c2ccccc2C1=O

Standard InChI:  InChI=1S/C21H15NO4/c23-19(24)12-18(15-10-9-13-5-1-2-6-14(13)11-15)22-20(25)16-7-3-4-8-17(16)21(22)26/h1-11,18H,12H2,(H,23,24)

Standard InChI Key:  CRZVCCHNDGGIAO-UHFFFAOYSA-N

Associated Targets(non-human)

TCTS-154 Trans-sialidase (45 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Trypanosoma cruzi (99888 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 345.35Molecular Weight (Monoisotopic): 345.1001AlogP: 3.65#Rotatable Bonds: 4
Polar Surface Area: 74.68Molecular Species: ACIDHBA: 3HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 4.03CX Basic pKa: CX LogP: 3.41CX LogD: 0.26
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.73Np Likeness Score: -0.40

References

1. Kashif M, Chacón-Vargas KF, López-Cedillo JC, Nogueda-Torres B, Paz-González AD, Ramírez-Moreno E, Agusti R, Uhrig ML, Reyes-Arellano A, Peralta-Cruz J, Ashfaq M, Rivera G..  (2018)  Synthesis, molecular docking and biological evaluation of novel phthaloyl derivatives of 3-amino-3-aryl propionic acids as inhibitors of Trypanosoma cruzi trans-sialidase.,  156  [PMID:30006170] [10.1016/j.ejmech.2018.07.005]

Source